Estudios
I+D+I
Institución
Internacional
Vida Universitaria
Universidad de Zaragoza Repository
Search
Submit
Personalize
Your alerts
Your baskets
Your searches
Help
EN
/
ES
Home
>
Articles
>
How many familial hypercholesterolemia patients are eligible for PCSK9 inhibition?
> Access to Fulltext
Usage statistics
Plots
How many familial hypercholesterolemia patients are eligible for PCSK9 inhibition?
-
Masana, L.
et al
- ART-2017-99677
Main
file(s):
texto_completo
version 1
texto_completo.jpg (icon)
[1.71 MB]
22 Jan 2024, 15:31
Postprint
texto_completo.pdf
[1.06 MB]
22 Jan 2024, 15:31
Postprint